Literature DB >> 20191374

Clinical features of pediatric Graves' orbitopathy.

J Eha1, S Pitz, J Pohlenz.   

Abstract

Pediatric Graves' orbitopathy is rare, thus its clinical picture is less well defined in comparison with the adult population. Therefore it is our aim to describe the clinical spectrum at our tertiary referral center. We identified 11 patients under the age of 18 years (3♂, 8♀; range 3-16 years, mean age 14.5 years) with Graves' disease and signs of orbitopathy. Seven of them where reevaluated (mean follow-up 25 months, range 3-66 months). Eyelid retraction and proptosis were the predominant signs in 10/11 of our patients. In six patients, Hertel readings ranged from 22 mm or above. Mild ocular motility impairment was seen in four children. Active orbitopathy or severe impairment of visual acuity/ocular motility, corneal or optic nerve involvement was not observed in our study. Our series confirms that pediatric Graves' orbitopathy lacks significant inflammatory features; however, proptosis is common and may be marked. All seven patients who were reevaluated did not show any clinically significant change of ocular signs during the observation period. In particular, there was no improvement of proptosis despite restoration of euthyroidism.

Entities:  

Mesh:

Year:  2010        PMID: 20191374     DOI: 10.1007/s10792-010-9351-6

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  20 in total

Review 1.  Review of the outcome of management of Graves' disease in children and adolescents.

Authors:  P Bergman; A W Auldist; F Cameron
Journal:  J Paediatr Child Health       Date:  2001-04       Impact factor: 1.954

2.  Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.

Authors:  M P Mourits; M F Prummel; W M Wiersinga; L Koornneef
Journal:  Clin Endocrinol (Oxf)       Date:  1997-07       Impact factor: 3.478

3.  Normal standards for exophthalmometry in children 10 to 14 years of age: relation to age, height, weight, and sexual maturation.

Authors:  F R Gerber; F H Taylor; M DeLevie; A L Drash; F M Kenny
Journal:  J Pediatr       Date:  1972-08       Impact factor: 4.406

4.  Natural history of thyroid associated ophthalmopathy.

Authors:  P Perros; A L Crombie; P Kendall-Taylor
Journal:  Clin Endocrinol (Oxf)       Date:  1995-01       Impact factor: 3.478

5.  Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease.

Authors:  Keiko Shibayama; Yoshihide Ohyama; Yukifumi Yokota; Shigeyuki Ohtsu; Noriyuki Takubo; Nobuo Matsuura
Journal:  Endocr J       Date:  2005-10       Impact factor: 2.349

6.  Surgical management of Graves disease in childhood and adolescence: an institutional experience.

Authors:  Jonathan Sherman; Geoffrey B Thompson; Aida Lteif; W Frederick Schwenk; Jon van Heerden; David R Farley; Seema Kumar; Donald Zimmerman; Marilyn Churchward; Clive S Grant
Journal:  Surgery       Date:  2006-11-01       Impact factor: 3.982

7.  Association between thyroid-stimulating immunoglobulin levels and ocular findings in pediatric patients with Graves disease.

Authors:  Olga M Acuna; Ioanna Athannassaki; Evelyn A Paysse
Journal:  Trans Am Ophthalmol Soc       Date:  2007

Review 8.  Prevention of thyroid associated-ophthalmopathy in children and adults: current views and management of preventable risk factors.

Authors:  Gerasimos E Krassas; Petros Perros
Journal:  Pediatr Endocrinol Rev       Date:  2007-03

9.  Prominent proptosis in childhood thyroid eye disease.

Authors:  G T Liu; K L Heher; J A Katowitz; M Kazim; G Moazami; T Moshang; J W Teener; J Sladky; N J Volpe; S L Galetta
Journal:  Ophthalmology       Date:  1996-05       Impact factor: 12.079

10.  Graves' ophthalmopathy in childhood and adolescence.

Authors:  S H Uretsky; J S Kennerdell; J P Gutai
Journal:  Arch Ophthalmol       Date:  1980-11
View more
  6 in total

1.  Incidence and clinical characteristics of pediatric eyelid retraction.

Authors:  Jessica A Olayanju; Gregory J Griepentrog; Brian G Mohney
Journal:  J AAPOS       Date:  2019-06-20       Impact factor: 1.220

2.  Age differences in clinical manifestation and prognosis of thyroid eye disease.

Authors:  Guy J Ben Simon; Gabriel Katz; Ofira Zloto; Hana Leiba; Beatrix Hadas; Ruth Huna-Baron
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-07       Impact factor: 3.117

3.  Predictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease.

Authors:  Dalia Jarusaitiene; Rasa Verkauskiene; Vytautas Jasinskas; Jurate Jankauskiene
Journal:  Int J Endocrinol       Date:  2016-06-16       Impact factor: 3.257

4.  Assessment of visual acuity, refraction changes, and proptosis in different ages of patients with thyroid diseases.

Authors:  J Jankauskiene; D Jarusaitiene
Journal:  Int J Endocrinol       Date:  2012-11-06       Impact factor: 3.257

5.  [Role and effectiveness of radioactive-iodine therapy for the treatment of Grave's disease].

Authors:  Ali Sellem; Wassim Elajmi; Rania Ben Mhamed; Nesrine Oueslati; Haroun Ouertani; Hatem Hammami
Journal:  Pan Afr Med J       Date:  2020-08-25

6.  Graves' Orbitopathy: Report of 82 cases.

Authors:  Samah Mbarek; Fatma Abid; Wafa Ammari; Wafa Alaya; Anis Mahmoud; Riadh Messaoud
Journal:  Tunis Med       Date:  2021-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.